Dose-response study of surfactant replacement in immature newborn rabbits

Prenatal and Neonatal Medicine

Volumn 4, Issue 1, 1999, Pages 71-78

  Bongrani, S ^c   Fornasier, M ^c   Papotti, M ^c   Razzetti, R ^c   Curstedt, T ^a   Robertson, B ^b  

^a Department of Clinical Chemistry ^*  (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c CHIESI FARMACEUTICI S P A   (Italy)

Author keywords

Drug dose response relationship; Lung function tests; Lung volume measurements; Newborn animals; Pulmonary surfactants; Respiratory distress syndrome

Indexed keywords

LUNG SURFACTANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG RESPONSE; IMMATURITY; NEWBORN DISEASE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RESPIRATORY DISTRESS SYNDROME; SURVIVAL; TREATMENT OUTCOME;

EID: 0032947705     PISSN: 13598635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. 1. Robertson B, Halliday HL. Principles of surfactant replacement. Biochim Biophys Acta 1998;1408:346-61
2. 2. Soll RF. In Robertson B, Taeusch HW, eds. Surfactant Therapy for Lung Disease. New York, USA: Marcel Dekker, 1995:407-41
3. 3. Boncuk-Dayanikli P, Taeusch HW. In Robertson B, Taeusch HW, eds. Surfactant Therapy for Lung Disease. New York, USA: Marcel Dekker, 1995: 217-38
4. 4. Fujiwara T, Robertson B. In Robertson B, van Golde LMG, Batenburg JJ, eds. Pulmonary Surfactant. From Molecular Biology to Clinical Practice. Amsterdam, The Netherlands: Elsevier, 1992: 561-92
5. 5. Robertson B, Curstedt T, Johansson J, Jörnvall H, Kobayashi T. Structural and functional characterization of porcine surfactant isolated by liquid-gel chromatography. Prog Respir Res 1990;25:237-46
6. 6. Lachmann B, Grossmann G, Freyse J, Robertson B. Lung-thorax compliance in the artificially ventilated premature rabbit neonate in relation to variations in inspiratory : expiratory ratio. Pediatr Res 1981;15: 833-8
7. 7. Berggren P, Curstedt T, Grossmann G, Nilsson R, Robertson B. Physiological activity of pulmonary surfactant with low protein content; effect of enrichment with synthetic phospholipids. Exp Lung Res 1985;8:29-51
8. 8. Scherle W. A simple method for volumetry of organs in quantitative stereology. Mikroskopie 1970;26:57-60
9. 9. Jobe A, Ikegami M. Surfactant for the treatment of respiratory distress syndrome. Am Rev Respir Dis 1987; 136:1256-75
10. 10. Marks LB, Notter RH, Oberdorster G, McBride JT. Ultrasonic and jet aerosolization of phospholipids and the effects on surface activity. Pediatr Res 1983;17: 742-7
11. 11. Kobayashi T, Shido A, Nitta K, Inui S, Murakami S, Robertson B. The critical concentration of surfactant in fetal lung liquid at birth. Respir Physiol 1990;80: 181-92
12. 12. Hallman M, Merritt TA, Pohjavuori M, Gluck L. Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure. Pediatr Res 1986;20:1228-35
13. 13. Speer CP, Robertson B, Curstedt T, Halliday HL, Compagnone D, Gefeller O, et al. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics 1992;89: 13-20
14. 14. Halliday HL, Tarnow-Mordi WO, Corcoran JD, Patterson CC. Multicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (The Curosurf 4 trial). Arch Dis Child 1993;69:276-80
15. 15. The Osiris Collaborative Group. Early versus delayed neonatal administration of a synthetic surfactant - the judgment of OSIRIS. Lancet 1992;340:1363-9
16. 16. Fiori RM, Diniz EMA, Lopes JMA, Concalves AL, da Costa MTZ, Marino WT, et al. Surfactant replacement therapy: a multicentric trial comparing two dosage approaches. Acta Bio-Medica de 'L'Ateneo Parmense' 1997;68:55-63
17. 17. Konishi M, Fujiwara T, Naito T, Takeuchi Y, Ogawa Y, Inukai K, et al. Surfactant replacement therapy in neonatal respiratory distress syndrome. A multicentre, randomized clinical trial: comparison of high-versus low-doses of Surfactant TA. Eur J Pediatr 1988;47: 20-5
18. 18. Gortner L, Pohlandt F, Bartmann P, Bernsau U, Porz F, Hellwege H-H, et al. High-dose versus low-dose bovine surfactant treatment in very premature infants. Acta Paediatr 1994;83:135-41
19. 19. Metcalfe IL, Pototschnik R, Burgoyne R, Enhorning G. Lung expansion and survival in rabbit neonates treated with surfactant extract. J Appl Physiol 1982;53: 838-43
20. 20. Disse B, Gortner L, Weller E, Eberhardt H, Ziegler H. In Lachmann B, ed. Surfactant Replacement Therapy in Neonatal and Adult Respiratory Distress Syndrome. Berlin: Springer-Verlag, 1988:37-41
21. 21. Enhörning G, Robertson B. Lung expansion in the premature rabbit fetus after tracheal deposition of surfactant. Pediatrics 1972;50:58-66
22. 22. Lachmann B. Possible function of bronchial surfactant. Eur J Res Dis 1985;67(Suppl 142):49-61
23. 23. Gommers D, Vilstrup C, Bos JAH, Larsson A, Werner O, Hannappel E, et al. Exogenous surfactant therapy increases static lung compliance, and cannot be assessed by measurements of dynamic compliance alone. Crit Care Med 1993;21:567-74